[Non-nucleoside antiherpetic agents].
Nishiyama
Y
Y
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006564:Herpesviridae / Q000254:growth & development; D006566:Herpesviridae Infections / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D007372:Interferons / Q000494:pharmacology / Q000627:therapeutic use; D007612:Kanamycin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D007659:Ketones / Q000494:pharmacology / Q000627:therapeutic use*; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D010746:Phosphonoacetic Acid / Q000494:pharmacology / Q000627:therapeutic use*
D000998:Antiviral Agents; D007659:Ketones; D009943:Organophosphorus Compounds; D007612:Kanamycin; C020706:arildone; D007372:Interferons; C056259:N(1)-pentadecanoyl-N(3'')-trifluoracetylkanamycin A; D010746:Phosphonoacetic Acid